Brinker Capital Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,469
Closed -$531K 1670
2022
Q4
$531K Sell
14,469
-13,567
-48% -$536K 0.01% 958
2022
Q3
$1.32M Buy
28,036
+654
+2% +$42.2K 0.03% 596
2022
Q2
$1.96M Buy
27,382
+804
+3% +$58.8K 0.04% 485
2022
Q1
$2.15M Sell
26,578
-5,527
-17% -$468K 0.03% 504
2021
Q4
$3.3M Sell
32,105
-3,226
-9% -$310K 0.05% 393
2021
Q3
$3.16M Hold
35,331
0.05% 397
2021
Q2
$3.16M Buy
35,331
+32,007
+963% +$2.7M 0.04% 453
2021
Q1
$252K Sell
3,324
-54,940
-94% -$4.14M ﹤0.01% 1099
2020
Q4
$3.97M Buy
58,264
+35,943
+161% +$2.24M 0.06% 382
2020
Q3
$1.19M Buy
+22,321
New +$1.33M 0.02% 634

Other funds holding SYNH

Brinker Capital Investments's SYNH Position: Q1 2023 in Review

Brinker Capital Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 14,469 shares — an estimated $531K sold.

Brinker Capital Investments first reported a position in SYNH in Q3 2020 and held it in 10 quarters. The position peaked at $3.97M in Q4 2020. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Brinker Capital Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 14,469 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $531K.
  • Brinker Capital Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2020 and held it in 10 quarters.
  • Brinker Capital Investments's Syneos Health, Inc. Class A Common Stock position peaked at $3.97M in Q4 2020.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Brinker Capital Investments's 13F filing for Q1 2023, filed 31 Jul 2025.